NCT00296127CompletedPhase 1
A Relative Bioavailability Study Of Celecoxib Administered As Capsule Contents Sprinkled On Applesauce In Healthy Adult Volunteers
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1 site in 1 country24 target enrollmentStarted: February 1, 2006Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 24
- Locations
- 1
- Primary Endpoint
- Relative bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative intact capsule after a single dose
Study Overview
Brief Summary
To evaluate the bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative to intact capsule
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 55 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Healthy male and/or female subjects
Exclusion Criteria
- •Standard criteria for healthy volunteer studies
Outcomes
Primary Outcomes
Relative bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative intact capsule after a single dose
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Bioavailability Study of Colcrys® in Apple JuiceHealthyNCT01123395Mutual Pharmaceutical Company, Inc.16
Completed
Phase 1
Bioavailability Study of Colcrys® Crushed and Sprinkled on ApplesauceHealthyNCT01130051Mutual Pharmaceutical Company, Inc.16
Completed
Phase 1
Relative Bioavailability of Colcrys™ 0.6 mg Tablets in Healthy Young and Elderly Volunteers Under Fasted ConditionsHealthyNCT01001052Mutual Pharmaceutical Company, Inc.38
Completed
Phase 1
Bioavailability of Apixaban Crushed TabletThrombosisNCT02101112Bristol-Myers Squibb69
Completed
Phase 1
Relative Bioavailability StudyHealthy VolunteersNCT02159313Bayer48